Sign In

Alexandre Gibim

General Manager Greater China at Novartis

Alexandre Gibim is a seasoned executive in the pharmaceutical industry, currently serving as the Chief Operations Officer (COO) at Nusano, Inc., a company focused on producing medical radioisotopes for cancer treatment. His extensive career spans over three decades, during which he has held significant roles in multinational operations and commercial strategies across various regions, including the United States, China, Canada, and Brazil.2

Prior to his role at Nusano, Gibim was the Senior Vice President and Head of North America at Advanced Accelerator Applications, a subsidiary of Novartis. In this capacity, he successfully led the U.S. launch of 177Lu-PSMA-617 (marketed as Pluvicto™), a groundbreaking radiopharmaceutical for prostate cancer.2 His leadership has been instrumental in driving substantial revenue growth and overseeing large teams within the pharmaceutical sector.

Gibim holds an educational background from the Kellogg School of Management at Northwestern University, which complements his practical experience in the industry.13 His expertise includes business transformation initiatives, go-to-market strategies, and managing complex operational challenges in high-growth environments.

In summary, Alexandre Gibim is recognized for his strategic insights and operational leadership in oncology and radiopharmaceuticals, making significant contributions to advancing cancer care through innovative therapies.

Highlights

Sep 15 · nusano.com
Appoints Industry Expert Alexandre Gibim as Chief Operations Officer

Related Questions

What are Alexandre Gibim's key achievements at Novartis Oncology?
How did Alexandre Gibim contribute to the launch of Pluvicto™?
What is Alexandre Gibim's educational background?
What roles has Alexandre Gibim held at Pfizer?
How did Alexandre Gibim's experience in China impact his career?
Alexandre Gibim
Add to my network

Location

Chaoyang Qu, Beijing, China